Patients with HIV are living longer and receiving better regimens of therapy. What are the renal replacement treatment options that are best suited to the patient presenting with HIV nephropathy? Special considerations in the dually complex disease process of HIV treatment and CKD are also discussed.
Contact hours available until 9/22/2015.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Conflict of Interest Disclosure: Speaker(s) have no disclosures to declare.
Conference Committee Disclosures: Dawn Koonkongsatian – Employee, Fresenius Medical Care Kristin Larson – Employee, NxStage Medical Denise Murcek – Employee, Fresenius Medical Care Beth St. John - Employee, Fresenius Medical Care Lucy Todd – Employee, Baxter Healthcare Kyra Trappett – Employee, DaVita
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Describe the pathophysiology of HIV nephropathy.
Describe the epidemiology, natural history, and course of HIV nephropathy.
Describe the treatment of HIV nephropathy, including the nephrotoxicity of the agents used.